Nephrology, Hypertension & Renal Transplantation

Faculty

Zvi Talor, M.D.

Dr. Talor is currently Professor of Medicine and the Director of Education in the Division of Nephrology, Hypertension and Renal Transplantation at the University of Florida, Course Director of Elective Consult Rotations for 4th Year Medical Students, and Medical Director of the Univeristy of Florida/DCI Dialysis Center. Dr. Talor received his medical degree from Hadassah Medical School at the Hebrew University in Jerusalem, Israel in 1973. He also was awarded B.Sc. in Chemistry in 1967 and M.Sc. in Biochemistry (with distinction) in 1970 from Hadassah Medical School. Dr. Talor completed a clinical fellowship in Nephrology at Rambam Hospital and Technion School of Medicine, Haifa, Israel, and a research fellowship at the section of Nephrology at University of Chicago. He joined the VA Medical Center in Little Rock Arkansas in 1983 as an Assistant Professor and he became the acting Chief of the Section of Nephrology a year later. In 1985 he moved back to Chicago where he became Chief of Nephrology at Westside VA Medical Center and Associate Professor of Medicine at the University of Illinois. In 1992 Dr. Talor was appointed chief of nephrology at St. Vincent Catholic Medical Centers of Brooklyn and Queens in New York, where he became Professor of Clinical Medicine at New York Medical College.

Dr. Talor received an Honorary Award of Distinction from Hadassah Medical School in 1971 and was six times the recipient of the "Teacher of the Year" award from the department of medicine at St. Vincent Catholic Medical Centers of Brooklyn and Queens. He is a member of the American Physiological Society, Central Society of Clinical Research and the American Federation for Clinical Research.

Selected Publications:

  • Gorin E, Talor, Z and Shafrir E. Glyceroneogenesis in adipose tissue of fasted, diabetic and triamcinolone treated rats. Europ J. Biochem 8: 370-375, 1969.
  • Sobel JD, Talor, Z, Alroy G, Lichtig C and Valero A. Systemic lupus erythematosus, Sjogren syndrome and glomerular nephritis. Postgrad Med J 53: 97-101, 1977.
  • Talor, Z, Blunted pressure response to volume load in conscious dogs with chronic bile duct ligation. Med Biol 60: 217-220, 1982.
  • Talor, Z, Emmanouel DS, and Katz AI. Insulin binding and degradation by luminal and basolateral tubular membranes from rabbit kidney. J Clin Invest 69: 1136-1146, 1982.
  • Talor, Z, Emmanuoel DS, and Katz AI. Glucagon degradation by luminal and basolateral rabbit tubular membranes. Am J. Physiol 224 (Renal fluid Electrolyte Physiol 13): F297-F303, 1983
  • Talor, Z, Richison G, and Arruda JAL. High affinity calcium binding sites in luminal and basolateral renal membranes. Am J. Physiol 248 (Renal Fluid Electrolyte Physiol 17): F472-F481, 1985.
  • Talor, Z, and Arruda JAL. Partial purification and reconstitution of renal basolateral Na-Ca exchanger into liposomes. J. Biol Chem 260: 15473- 15476, 1985.
  • Talor, Z, Gold R, Yang WC, and Arruda JAL. Anion exchanger is present in both luminal and basolateral tubular renal membranes. Eur J. Biochem 164:695-702, 1987.
  • Talor, Z, Lubansky JH, and Arruda JAL. Relationship of K and ammonia transport by the turtle bladder. Mineral and Electrolyte Metab 13: 78-84, 1987.
  • Talor, Z, Yang WC, Shuffield J, Sack EM, and Arruda JAL. Chronic hypercapnia enhances Vmax of Na-H antiporter. Am J. Physiol 253 (Renal Fluid Electrolyte Physiol 22): F394-F400, 1987.
  • Talor, Z, Arruda JAL. Renal basolateral membranes Na-Ca exchange is Electrogenic. Mineral and Electrolyte Metab 13: 183-188, 1987.
  • Yang WC, Arruda JAL and Talor, Z. Na-H antiporter in the post-hypercapnia state. Am J Physiol 253 (Renal Fluid Electrolyte Physiol 22): F833-F840, 1987.
  • Chang CS, Talor, Z, and Arruda JAL. Effect of metabolic or respiratory acidosis on rabbit renal medullary proton ATPase. Biochemistry and Cell Biology 66: 20-24, 1988.
  • Talor, Z, and Mejicano GC. Phorbol-ester is bound specifically to renal luminal membranes and stimulates the Na-H antiporter. Res Comm in Chem Path and Pharm 61: 335-343, 1988.
  • Ruiz OS, Arruda JAL, and Talor, Z. Na-HCO3 cotransport and Na-H antiporter in chronic respiratory acidosis and alkalosis Am J. Physiol 256 (Renal Fluid Electrolyte Physiol 25): F414-F420, 1989.
  • Talor, Z, Ng SC, Cragoe EJ and Arruda JAL. Methyl isobutyl amiloride: A new probe to assess the number of Na-H antiporters. Life Sciences 45: 517-523, 1989.
  • Ruiz OS, Talor, Z, and Arruda JAL. Regional localization of renal Na-H antiporter: Response to respiratory acidosis. Am J. Physiol 259 (Renal Fluid Electrolyte Physiol 28): F512-F518, 1990.

Research Interest

Current Research interests are related to Clinical Nephrology and Hypertension.

We are participating in a multi-center study to assess the effect of an oral derivative of Vitamin D on prevention of renal osteodystrophy in patients with Chronic Kidney Disease. We also participate in a multi-center study to assess the effect of weekly administration of erythropoietin on Cardio-Vascular morbidity and mortality in patients with CKD and we participate in a VA cooperative study "Homocysteinemia in Kidney and End Stage Renal Disease Study".

Primary Navigation